Robert Langer wins BBVA Foundation Frontiers of Knowledge Award Robert Langer, the David H Koch (1962) Institute Professor at MIT, received yesterday the 2022 BBVA Foundation Frontiers of Knowledge Award in Biology and Biomedicine in recognition of his contributions to messenger (mRNA) therapeutics and delivery technology, which enabled the rapid development of SARS-CoV-2 vaccines
The power of ‘convergence’ - MIT News The report gives particular focus to biomedicine, a field that is already being transformed by convergence At MIT, for example, scientists are using nanoparticles to transport time-release anticancer drugs directly to cancerous cells, developing drugs that fight diseases without damaging healthy tissues and cells, and improving new predictive
Study: NIH funding generates large numbers of private-sector patents . . . Newsweek reporter Jessica Wapner writes about a new study by MIT researchers that provides evidence that NIH funding contributes to a large number of patents in the field of biomedicine The findings indicate that NIH-funded research “is not being done in an ivory tower,” explains Prof Pierre Azoulay
New US postage stamp highlights MIT research The stamp is part of a new U S Postal Service (USPS) series on innovation, representing computing, biomedicine, genome sequencing, robotics, and solar technology For the robotics category, the USPS chose the bionic prosthesis designed and built by Matt Carney PhD ’20 and members of the Biomechatronics group, led by Professor Hugh Herr
Robert Langer receives Dr. Paul Janssen Award - MIT News MIT Institute Professor Robert S Langer was recently honored with the 2023 Dr Paul Janssen Award for his groundbreaking work in designing novel drug delivery systems that can deliver medications continuously, precisely, and at controlled rates over extended periods
Emeritus: Engineering a new path - MIT News At the time, only a handful of engineers around the United States were delving into biomedicine Merrill’s colleagues told him that his work in blood rheology might undermine his shot at tenure But the risk paid off, and Merrill went on to launch biomedical engineering as a major focus of MIT’s chemical engineering department, influencing
Could LLMs help design our next medicines and materials? The process of discovering molecules that have the properties needed to create new medicines and materials is cumbersome and expensive, consuming vast computational resources and months of human labor to narrow down the enormous space of potential candidates
MIT researchers introduce Boltz-1, a fully open-source model for . . . Researchers in the MIT Jameel Clinic for Machine Learning in Health developed a fully open-source biomolecular structure prediction model that achieves state-of-the-art performance, at the level of AlpahFold3, in an effort to democratize biomedical research and drug development